Funds award for breast cancer study

Dr Francis Mprah Barnieh, an early-career researcher at the University of Bradford, has been awarded £236,455 under the competitive Wellcome Accelerator Award scheme. Credit: University of Bradford.placeholder image
Dr Francis Mprah Barnieh, an early-career researcher at the University of Bradford, has been awarded £236,455 under the competitive Wellcome Accelerator Award scheme. Credit: University of Bradford.

A UNIVERSITY of Bradford researcher has been awarded £236,455 to advance the development of safer and more targeted treatments from triple-negative breast cancer.

Dr Francis Mprah Barnieh, inset, secured the funds under the Wellcome Accelerator Award scheme, which supports researchers of black, Bangladeshi and Pakistani heritage to strengthen their research profile.

He uncovered a previously unknown mechanism that enables cancer cells to survive in low-oxygen tumour environments.

His latest two-year project will develop innovative “smart” drugs that are activated only within oxygen-poor tumours, allowing more precise targeting of cancer cells while minimising damage to healthy tissue and reducing side effects.

Triple-negative breast cancer. is one of the most aggressive and difficult-to-treat forms of breast cancer and disproportionately affects black women.

Dr Barneith said: "This award provides an opportunity to accelerate my career and support my research vision of developing safer, more effective therapies that can make a real difference for patients while addressing long-standing inequities in cancer research.”

Related topics:
News you can trust since 1754
Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice